Institutional Investors Are Betting On Corcept Therapeutics Inc (NASDAQ:CORT)


Starbucks Corp now has $84.53B valuation. In the current trading session, the stock has seen a change of -4.80% recently hitting $15.88. The volume of 0.67 Million shares climbed down over an trading activity of 412.43 Million shares.

Shares of Corcept Therapeutics (NASDAQ:CORT) now have an Average Brokerage Recommendation of 1.75, number of Recs in ABR is 4 while industry rank of the company by ABR is out of 265. It has underperformed by 4.22% the S&P500. Evanson Asset Ltd Liability Corp has invested 0.11% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. About 938,744 shares traded.

Taking a broader look at the analyst consensus, according to 5 analysts Corcept Therapeutics (NASDAQ:CORT)'s price will reach at $17.8 during 52 weeks. It was reported on Dec, 5 by

Investors sentiment increased to 2.43 in 2017 Q2. Its up 1.35, from 1.08 in 2017Q1. It increased, as 11 investors sold Corcept Therapeutics Incorporated shares while 29 reduced holdings. That's a potential 24.4 increase relative to where Corcept Therapeutics Incorporated (NASDAQ:CORT) has been trading recently. Fincl Bank Of New York Mellon Corp stated it has 926,350 shares. Barometer Cap Mgmt, Ontario - Canada-based fund reported 229,400 shares. Los Angeles Capital Management & Equity Research Inc. owned approximately 0.06% of Corcept Therapeutics worth $1,352,000 at the end of the most recent quarter. Manufacturers Life Ins The accumulated 181,414 shares. Wells Fargo & Company Mn reported 96,081 shares.

Among 4 analysts covering Corcept Therapeutics (NASDAQ:CORT), 4 have Buy rating, 0 Sell and 0 Hold. Whitnell And Communications owns 17,900 shares for 0.35% of their portfolio. Vanguard Gru invested in 4.44M shares. Secor Cap Advisors Lp has 36,689 shares. Millennium Management Lc owns 652,162 shares. Sg Americas Securities Ltd Llc holds 0% or 9,255 shares.

Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of 103.76 and a beta of 1.72. It offers Korlym tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It has a 14.26 P/E ratio. For the past 5 years, the company's revenue has grown 0%, while the company's earnings per share has grown 16.9%. CORT's profit will be $21.69M for 21.95 P/E if the $0.19 EPS becomes a reality. During the same period in the prior year, the company earned $0.02 EPS. equities research analysts expect that Corcept Therapeutics Incorporated will post 0.47 EPS for the current fiscal year.

Ratings analysis reveals 100% of Corcept Therapeutics's analysts are positive. Therefore 100% are positive. Corcept Therapeutics Incorporated has a fifty-two week low of $6.70 and a fifty-two week high of $20.77. Corcept Therapeutics had 7 analyst reports since February 2, 2017 according to SRatingsIntel. The stock has "Buy" rating by Stifel Nicolaus on Friday, November 3. Corcept Therapeutics presently has a consensus rating of "Buy" and an average target price of $18.20.

Since June 14, 2017, it had 0 insider buys, and 1 insider sale for $606,300 activity. 104 funds opened positions while 473 raised stakes. The funds in our partner's database now have: 67.64 million shares, up from 60.14 million shares in 2017Q1. Tfs Capital Limited Liability holds 10,692 shares. Cs Mckee Lp holds 273,780 shares.

Shares of Corcept Therapeutics (CORT) remained flat at $$16.68 on Tuesday. Gibraltar Industries, Inc. (ROCK) has risen 13.48% since December 4, 2016 and is uptrending. Convergence Inv Prns Limited Liability, a Wisconsin-based fund reported 111,231 shares. 121,246 were reported by Stephens Ar. Prudential reported 633,223 shares or 0.01% of all its holdings. Out of 4 Wall Street analysts rating Corcept Therapeutics, 4 give it "Buy", 0 "Sell" rating, while 0 recommend "Hold". As per Thursday, September 28, the company rating was maintained by Keefe Bruyette & Woods. KeyBanc Capital Markets maintained the shares of BABA in report on Friday, August 18 with "Overweight" rating. There are brokerage firms with lower targets than the average, including one setting a price target of $6. Earnings surprises can have a huge impact on a company's stock price. The company was initiated on Tuesday, April 5 by Evercore. On Wednesday, August 12 the stock rating was maintained by Nomura with "Buy". The firm earned "Buy" rating on Thursday, January 21 by Standpoint Research.



Related Posts

The Boring Company illustrates its plans for LA tunnels
Interested in solar? Get a solar cost estimate and find out how much a solar system would cost for your home or business. A map with Phase 1 of the project, the proof-of-concept tunnel, highlighted in red and Phase 2 highlighted in blue.

Stipe Miocic - Francis Ngannou Bout Reportedly Planned For UFC 220
Miocic (17-2) will attempt to become the longest-reigning heavyweight champion in UFC history. It's unclear which of the two title fights would serve as the UFC 220 main event.

Pentagon: US committed to Syria until ISIS areas stabilized
The department had previously omitted forces on temporary rotation from the count, along with a number of other groups. McMaster said that as much as 80% of pro-Assad forces in Syria are proxy forces controlled by Iran.

Ryan Reynolds has been cast as Detective Pikachu in the upcoming movie
Ryan Reynolds is readying to catch 'em all in a new installment of one of the world's biggest franchises. Universal Pictures will handle distribution in the USA and in foreign territories outside Japan.

Senegalese Trio Handed FIFA Club World Cup 2017 Opener
Meanwhile, Vicelich, who is New Zealand's most-capped global in history, is attending his 7th FIFA Club World Cup. It wasn't to be, however, and UAE 2017 won't be joining Morocco 2014 or UAE 2009 in the City storybook.

Revance Therapeutics, Inc. (RVNC)
Finally, Parametric Portfolio Associates LLC increased its stake in Revance Therapeutics by 5.9% in the first quarter. Granite Investment Ptnrs Ltd Liability Corporation has invested 0.12% of its portfolio in Revance Therapeutics, Inc .

Cardinal Health (NYSE:CAH) Downgraded by Morgan Stanley to "Underweight"
Thompson Siegel & Walmsley LLC owned about 0.46% of Cardinal Health worth $97,002,000 as of its most recent filing with the SEC. Cardinal Health, Inc. (NYSE:CAH) is another stock that is grabbing investors attention these days. (NYSE:CAH) or 2,825 shares.

Analyst Earnings Estimates Scan: Western Gas Partners, LP (NYSE:WES)
State of New Jersey Common Pension Fund D raised its holdings in shares of Western Gas Partners by 58.1% in the third quarter. The stock has performed 4.04% over the last seven days, -4.62% over the last thirty, and -9.59% over the last three months.

Jeffrey Tambor's Future with 'Transparent' is Still Unsure
Tambor has starred as transgender matriarch Pfefferman since 2014. IndieWire has reached out for an official comment from Amazon. Tambor responded in a statement where he denied those claims .

Man charged with Prince George-related terror offence
The prince is protected by royal bodyguards as well as London police, and the school itself also has security arrangements. Then in September, a woman was arrested at the school after trying to get into the property twice within 24 hours.

© 2015 ExpressNewsline. All Rights reserved.